{
    "clinical_study": {
        "@rank": "164728", 
        "acronym": "no", 
        "arm_group": {
            "arm_group_label": "no treatment", 
            "description": "non-randomized, all subjects who have been implanted with an ICD or CRT-D for at least 3 months"
        }, 
        "brief_summary": {
            "textblock": "A prospective post-market study to evaluate the performance and clinic usability of heart\n      failure risk status (HFRS) feature on CareLink."
        }, 
        "brief_title": "Integrated Diagnostic for Heart Failure", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "Patients with systolic heart failure (HF) implanted with Medtronic wireless implantable\n      cardiac defibrillator (ICD) or cardiac resynchronization therapy device with defibrillation\n      capabilities (CRT-D) devices will be enrolled in the study. The purpose of the study is to\n      evaluate the usability of CareLink HFRS to manage a patient's heart failure."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is 18 years of age or older\n\n          -  Patient ( or patient's legally authorized representative) is willing and able to\n             provide written informed consent\n\n          -  Patient is willing and able to comply with the required study follow up visits\n\n          -  Patient is implanted with a Medtronic wireless ICD or CRT-D device capable of OptiVol\n             fluid monitoring feature\n\n          -  Patient is on Medtronic CareLink network or is willing to be enrolled on the CareLink\n             network\n\n          -  Patient is being managed, or has been managed, by a HF clinician\n\n          -  Patient has signed an informed consent for CareLink Network Services\n\n          -  Patient is implanted with device for at least three months\n\n          -  Patient is willing and able to transmit data using the CareLink home monitor (2490C).\n\n        Exclusion Criteria:\n\n          -  Patient is  participating in another study that may interfere with TRIAGE-HF protocol\n             required procedures\n\n          -  Patient with an implantable cardiac device that is indicated to  reach ERI in less\n             than 12 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects with heart failure who have been implanted with an ICD or a CRT-D wirless device\n        for at least 3 months"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01798797", 
            "org_study_id": "TRIAGE-HF"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Heart Failure", 
            "HFRS", 
            "OptiVol", 
            "ICD", 
            "CRT-D"
        ], 
        "lastchanged_date": "September 3, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Sean Virani, MD", 
                    "phone": "604-875-5092"
                }, 
                "contact_backup": {
                    "last_name": "Naomi Uchida, RN", 
                    "phone": "604-975-4521"
                }, 
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V5Z 1M9"
                    }, 
                    "name": "Vancouver General Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Sean Viani, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Matthew Bennett, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Shelley Zieroth, MD", 
                    "phone": "204-237-2744"
                }, 
                "contact_backup": {
                    "last_name": "Angie Munoz, RN", 
                    "phone": "204-237-2793"
                }, 
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R2H 2A6"
                    }, 
                    "name": "St. Boniface Hospital"
                }, 
                "investigator": {
                    "last_name": "Shelley Zieroth, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Integrated Diagnostic for Heart Failure", 
        "overall_official": {
            "affiliation": "Vancouver General Hospital, Vancouver, British Columbia, Canada", 
            "last_name": "Sean Virani, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The clinical signs and symptoms of worsening HF that are associated with an Heart Failure Risk Status triggered by an OptiVol alert", 
            "measure": "Heart Failure Risk Status Performance Characterization", 
            "safety_issue": "No", 
            "time_frame": "from baseline until a subject completes 8 months of follow up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01798797"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The correlation between HFRS burden and clinician's assessment of a subject risk and the subject's medical management", 
            "measure": "Heart Failure Risk Status and medical management", 
            "safety_issue": "No", 
            "time_frame": "from baseline for each subject until they complete 8 months of follow up"
        }, 
        "source": "Medtronic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}